You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 120 No. 3, September 1967 TABLE OF CONTENTS
  Archives
  •  Online Features
  ARTICLES
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Anemia, Positive Lupus and Rheumatoid Factors With Methyldopa

A Report of Three Cases

Joseph D. Sherman, MD, PhD; Donald E. Love, MD; J. Frederick Harrington, MD

Arch Intern Med. 1967;120(3):321-326.

Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

There have been 22 reported cases of Coombs'-positive hemolytic anemia in patients under hypertensive treatment with methyldopa (Aldomet).1-7,18 In addition, 56 cases have been reported in which the direct Coombs' test was positive without hemolytic anemia.8-10,18 It would appear that the incidence of Coombs' positivity is dosage dependent.9 The purpose of this report is to describe three cases of Coombs'-positive hemolytic anemia in patients treated with methyldopa. The rheumatoid factor and the lupus erythematosus (LE) preparation were also positive in two of these cases. These latter two antibodies are described for the first time in patients given this drug.

Report of Cases

CASE 1.

—A 71-year-old white married woman was admitted to this hospital with complaints of progressive dyspnea and weakness of approximately one month's duration. The patient had essential hypertension diagnosed in 1949 and had been on methyldopa therapy from June 5, 1964, to the day . . . [Full Text PDF of this Article]


Author Affiliations

Framingham and Boston, Mass

From the Department of Hematology and Medicine, Framingham (Mass) Union Hospital, and the Department of Medicine, Boston University Medical Center, Boston.


Footnotes

Received for publication April 4, 1967; accepted May 23.

Reprint requests to Framingham Union Hospital, Department of Hematology, Framingham, Mass 01701 (Dr. Sherman).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1967 American Medical Association. All Rights Reserved.